Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
CJC-1295 shows similar characteristics, though the DAC (Drug Affinity Complex) modified version may exhibit slightly different degradation kinetics
A common stack protocol: 250-500 mcg BPC-157 + 2-2.5 mg TB-500 twice per week
Potential benefits may include: Supports appetite regulation Supports metabolic health goals May provide an alternative treatment approach when clinically appropriate Supports a comprehensive physician-directed weight management program Your provider will determine whether this treatment option is appropriate based on your medical history, health goals, and clinical evaluation
Currently, long-acting GLP-1 agonists dominate the GLP-1 market, and this trend is expected to persist in the coming years
The scientist who created it, has a team of scientists at the University of Copenhage, who our team works directly with
Your PlexusDx clinician can assess whether dose adjustment or medication change is warranted
